Cromatograma HPLC

You might also like

Download as pdf or txt
Download as pdf or txt
You are on page 1of 37

D-7000 HSM: MERCK LACHROM Series: 6966 Report: modified System: HPLC

Flemalis
Analyzed Date and Time: 29/10/18 03:28 p.m.
Processing Method: FLEMALIS BREMYMG
System(acquisition): HPLC Series:6966
Sample Name: STD FLEMALIS Apt sistema Vial Number: 1
Injection from this vial: 1 of 1 Vial Type: UNK
Sample Description: STD FLEMALIS Apt Volume: 20,0 ul
sistemas
Chrom Type: HPLC Channel : 1

2000

17103083, GUAYACOLATO DE GLICERILO


2920434, N-ACETILCISTEINA

1500
Intensity (mV)

1000

500

0 1 2 3 4 5 6 7 8 9 10
Retention Time (min)

Acquisition Method: FLEMALIS BREMYMG


Developed by: SAF SAS.
Pump A Type: L-7100
Solvent A: AGUA Solvent B: METANOL
Solvent C: FASE MOVIL Solvent D: AGUA
Method Description: Valoración Flemalis ( Guayacolato de Glicerilo + N-
Acetilcisteina)
Chrom Type: HPLC Channel : 1
Peak Quantitation: AREA
No. Name RT Area

1 N-ACETILCISTEINA 1,77 2920434


2 GUAYACOLATO DE GLICERILO 2,55 17103083

20023517

Peak rejection level: 500000

Page Indicator 1 / 43
D-7000 HSM: MERCK LACHROM Series: 6966 Report: modified System: HPLC

APTITUD DEL SISTEMA

System Suitability Report (Full width)


Processing Method: FLEMALIS BREMYMG
System (acquisition): HPLC
Sample Name: STD FLEMALIS Apt sistema
Injection from this vial: 1 of 1
Sample Description: STD FLEMALIS Apt sistemas

RT of Non-Retained Peak: 0,01 min

RT Name k' Asym N Res


(min) (USP) (USP)

1,77 N-ACETILCISTEINA 176,00 1,07 822 ---


2,55 GUAYACOLATO DE GLICERILO 254,00 1,50 1821 3,21

RT Name Alpha S/N Noise


(min) (uV)

1,77 N-ACETILCISTEINA --- --- ---


2,55 GUAYACOLATO DE GLICERILO 1,44 --- ---

Asymmetry warning outside the range of: 0,800 to 2,000


No. of theoretical plates warning at less than: 500
Resolution warning at less than: 0,800
Signal to noise ratio warning at less than: 3

Page Indicator 2 / 43
D-7000 HSM: MERCK LACHROM Series: 6966 Report: modified System: HPLC
Vial Summary for Channel 1
Chrom Type: HPLC Channel : 1
Vial Number: 1
Name Mean Conc 1 1 Mean
RT(min) CONC1

N-ACETILCISTEINA 1,77 0,000000 0,000000


GUAYACOLATO DE GLICERILO 2,55 0,000000 0,000000

Statistics Report for Repetitive Injections (Channel 1)


Vial Number: 1 Injections: 1
Concentration (Conc1)

Name Mean Conc 1 Standard % Standard Variance


Deviation Deviation

N-ACETILCISTEINA 0,000000 --- --- ---


GUAYACOLATO DE GLICERILO 0,000000 --- --- ---

Retention Time

Name Mean Standard % Standard Variance


RT(Min) Deviation Deviation

N-ACETILCISTEINA 1,770 --- --- ---


GUAYACOLATO DE GLICERILO 2,550 --- --- ---

Page Indicator 3 / 43
D-7000 HSM: MERCK LACHROM Series: 6966 Report: modified System: HPLC

Flemalis
Analyzed Date and Time: 29/10/18 03:34 p.m.
Processing Method: FLEMALIS BREMYMG
System(acquisition): HPLC Series:6966
Sample Name: STD FLEMALIS Vial Number: 1
Injection from this vial: 1 of 3 Vial Type: UNK
Sample Description: Volume: 20,0 ul
Chrom Type: HPLC Channel : 1

2000

17196475, GUAYACOLATO DE GLICERILO


3238578, N-ACETILCISTEINA

1500
Intensity (mV)

1000

500

0 1 2 3 4 5 6 7 8 9 10
Retention Time (min)

Acquisition Method: FLEMALIS BREMYMG


Developed by: SAF SAS.
Pump A Type: L-7100
Solvent A: AGUA Solvent B: METANOL
Solvent C: FASE MOVIL Solvent D: AGUA
Method Description: Valoración Flemalis ( Guayacolato de Glicerilo + N-
Acetilcisteina)
Chrom Type: HPLC Channel : 1
Peak Quantitation: AREA
No. Name RT Area

1 N-ACETILCISTEINA 1,77 3238578


2 GUAYACOLATO DE GLICERILO 2,53 17196475

20435053

Peak rejection level: 500000

Page Indicator 4 / 43
D-7000 HSM: MERCK LACHROM Series: 6966 Report: modified System: HPLC

APTITUD DEL SISTEMA

System Suitability Report (Full width)


Processing Method: FLEMALIS BREMYMG
System (acquisition): HPLC
Sample Name: STD FLEMALIS
Injection from this vial: 1 of 3
Sample Description:

RT of Non-Retained Peak: 0,01 min

RT Name k' Asym N Res


(min) (USP) (USP)

1,77 N-ACETILCISTEINA 176,33 1,12 772 ---


2,53 GUAYACOLATO DE GLICERILO 251,67 1,53 1717 3,02

RT Name Alpha S/N Noise


(min) (uV)

1,77 N-ACETILCISTEINA --- --- ---


2,53 GUAYACOLATO DE GLICERILO 1,43 --- ---

Asymmetry warning outside the range of: 0,800 to 2,000


No. of theoretical plates warning at less than: 500
Resolution warning at less than: 0,800
Signal to noise ratio warning at less than: 3

Page Indicator 5 / 43
D-7000 HSM: MERCK LACHROM Series: 6966 Report: modified System: HPLC

Flemalis
Analyzed Date and Time: 29/10/18 03:40 p.m.
Processing Method: FLEMALIS BREMYMG
System(acquisition): HPLC Series:6966
Sample Name: STD FLEMALIS Vial Number: 1
Injection from this vial: 2 of 3 Vial Type: UNK
Sample Description: Volume: 20,0 ul
Chrom Type: HPLC Channel : 1

2000

17101913, GUAYACOLATO DE GLICERILO


3213403, N-ACETILCISTEINA

1500
Intensity (mV)

1000

500

0 1 2 3 4 5 6 7 8 9 10
Retention Time (min)

Acquisition Method: FLEMALIS BREMYMG


Developed by: SAF SAS.
Pump A Type: L-7100
Solvent A: AGUA Solvent B: METANOL
Solvent C: FASE MOVIL Solvent D: AGUA
Method Description: Valoración Flemalis ( Guayacolato de Glicerilo + N-
Acetilcisteina)
Chrom Type: HPLC Channel : 1
Peak Quantitation: AREA
No. Name RT Area

1 N-ACETILCISTEINA 1,77 3213403


2 GUAYACOLATO DE GLICERILO 2,53 17101913

20315316

Peak rejection level: 500000

Page Indicator 6 / 43
D-7000 HSM: MERCK LACHROM Series: 6966 Report: modified System: HPLC

APTITUD DEL SISTEMA

System Suitability Report (Full width)


Processing Method: FLEMALIS BREMYMG
System (acquisition): HPLC
Sample Name: STD FLEMALIS
Injection from this vial: 2 of 3
Sample Description:

RT of Non-Retained Peak: 0,01 min

RT Name k' Asym N Res


(min) (USP) (USP)

1,77 N-ACETILCISTEINA 176,33 1,12 768 ---


2,53 GUAYACOLATO DE GLICERILO 251,67 1,52 1707 3,01

RT Name Alpha S/N Noise


(min) (uV)

1,77 N-ACETILCISTEINA --- --- ---


2,53 GUAYACOLATO DE GLICERILO 1,43 --- ---

Asymmetry warning outside the range of: 0,800 to 2,000


No. of theoretical plates warning at less than: 500
Resolution warning at less than: 0,800
Signal to noise ratio warning at less than: 3

Page Indicator 7 / 43
D-7000 HSM: MERCK LACHROM Series: 6966 Report: modified System: HPLC

Flemalis
Analyzed Date and Time: 29/10/18 03:45 p.m.
Processing Method: FLEMALIS BREMYMG
System(acquisition): HPLC Series:6966
Sample Name: STD FLEMALIS Vial Number: 1
Injection from this vial: 3 of 3 Vial Type: UNK
Sample Description: Volume: 20,0 ul
Chrom Type: HPLC Channel : 1

2000

17135513, GUAYACOLATO DE GLICERILO


3239607, N-ACETILCISTEINA

1500
Intensity (mV)

1000

500

0 1 2 3 4 5 6 7 8 9 10
Retention Time (min)

Acquisition Method: FLEMALIS BREMYMG


Developed by: SAF SAS.
Pump A Type: L-7100
Solvent A: AGUA Solvent B: METANOL
Solvent C: FASE MOVIL Solvent D: AGUA
Method Description: Valoración Flemalis ( Guayacolato de Glicerilo + N-
Acetilcisteina)
Chrom Type: HPLC Channel : 1
Peak Quantitation: AREA
No. Name RT Area

1 N-ACETILCISTEINA 1,78 3239607


2 GUAYACOLATO DE GLICERILO 2,54 17135513

20375120

Peak rejection level: 500000

Page Indicator 8 / 43
D-7000 HSM: MERCK LACHROM Series: 6966 Report: modified System: HPLC

APTITUD DEL SISTEMA

System Suitability Report (Full width)


Processing Method: FLEMALIS BREMYMG
System (acquisition): HPLC
Sample Name: STD FLEMALIS
Injection from this vial: 3 of 3
Sample Description:

RT of Non-Retained Peak: 0,01 min

RT Name k' Asym N Res


(min) (USP) (USP)

1,78 N-ACETILCISTEINA 176,83 1,11 770 ---


2,54 GUAYACOLATO DE GLICERILO 252,67 1,47 1692 3,02

RT Name Alpha S/N Noise


(min) (uV)

1,78 N-ACETILCISTEINA --- --- ---


2,54 GUAYACOLATO DE GLICERILO 1,43 --- ---

Asymmetry warning outside the range of: 0,800 to 2,000


No. of theoretical plates warning at less than: 500
Resolution warning at less than: 0,800
Signal to noise ratio warning at less than: 3

Page Indicator 9 / 43
D-7000 HSM: MERCK LACHROM Series: 6966 Report: modified System: HPLC
Vial Summary for Channel 1
Chrom Type: HPLC Channel : 1
Vial Number: 1
Name Mean Conc 1 1 Conc 1 2 Conc 1 3 Mean
RT(min) CONC1

N-ACETILCISTEINA 1,78 0,000000 0,000000 0,000000 0,000000


GUAYACOLATO DE GLICERILO 2,53 0,000000 0,000000 0,000000 0,000000

Statistics Report for Repetitive Injections (Channel 1)


Vial Number: 1 Injections: 1, 2, 3
Concentration (Conc1)

Name Mean Conc 1 Standard % Standard Variance


Deviation Deviation

N-ACETILCISTEINA 0,000000 0,000E+00 --- 0,000E+00


GUAYACOLATO DE GLICERILO 0,000000 0,000E+00 --- 0,000E+00

Retention Time

Name Mean Standard % Standard Variance


RT(Min) Deviation Deviation

N-ACETILCISTEINA 1,775 2,886E-03 0,16 8,333E-06


GUAYACOLATO DE GLICERILO 2,530 5,773E-03 0,23 3,333E-05

Page Indicator 10 / 43
D-7000 HSM: MERCK LACHROM Series: 6966 Report: modified System: HPLC

Flemalis
Analyzed Date and Time: 29/10/18 03:51 p.m.
Processing Method: FLEMALIS BREMYMG
System(acquisition): HPLC Series:6966
Sample Name: STD FLEMALIS Vial Number: 2
Injection from this vial: 1 of 3 Vial Type: UNK
Sample Description: Volume: 20,0 ul
Chrom Type: HPLC Channel : 1

2000

20027539, GUAYACOLATO DE GLICERILO


3294273, N-ACETILCISTEINA

1500
Intensity (mV)

1000

500

0 1 2 3 4 5 6 7 8 9 10
Retention Time (min)

Acquisition Method: FLEMALIS BREMYMG


Developed by: SAF SAS.
Pump A Type: L-7100
Solvent A: AGUA Solvent B: METANOL
Solvent C: FASE MOVIL Solvent D: AGUA
Method Description: Valoración Flemalis ( Guayacolato de Glicerilo + N-
Acetilcisteina)
Chrom Type: HPLC Channel : 1
Peak Quantitation: AREA
No. Name RT Area

1 N-ACETILCISTEINA 1,76 3294273


2 GUAYACOLATO DE GLICERILO 2,52 20027539

23321812

Peak rejection level: 500000

Page Indicator 11 / 43
D-7000 HSM: MERCK LACHROM Series: 6966 Report: modified System: HPLC

APTITUD DEL SISTEMA

System Suitability Report (Full width)


Processing Method: FLEMALIS BREMYMG
System (acquisition): HPLC
Sample Name: STD FLEMALIS
Injection from this vial: 1 of 3
Sample Description:

RT of Non-Retained Peak: 0,01 min

RT Name k' Asym N Res


(min) (USP) (USP)

1,76 N-ACETILCISTEINA 174,50 1,00 752 ---


2,52 GUAYACOLATO DE GLICERILO 250,50 1,24 1560 2,98

RT Name Alpha S/N Noise


(min) (uV)

1,76 N-ACETILCISTEINA --- --- ---


2,52 GUAYACOLATO DE GLICERILO 1,44 --- ---

Asymmetry warning outside the range of: 0,800 to 2,000


No. of theoretical plates warning at less than: 500
Resolution warning at less than: 0,800
Signal to noise ratio warning at less than: 3

Page Indicator 12 / 43
D-7000 HSM: MERCK LACHROM Series: 6966 Report: modified System: HPLC

Flemalis
Analyzed Date and Time: 29/10/18 03:58 p.m.
Processing Method: FLEMALIS BREMYMG
System(acquisition): HPLC Series:6966
Sample Name: STD FLEMALIS Vial Number: 2
Injection from this vial: 2 of 3 Vial Type: UNK
Sample Description: Volume: 20,0 ul
Chrom Type: HPLC Channel : 1

2000

20435123, GUAYACOLATO DE GLICERILO


3241393, N-ACETILCISTEINA

1500
Intensity (mV)

1000

500

0 1 2 3 4 5 6 7 8 9 10
Retention Time (min)

Acquisition Method: FLEMALIS BREMYMG


Developed by: SAF SAS.
Pump A Type: L-7100
Solvent A: AGUA Solvent B: METANOL
Solvent C: FASE MOVIL Solvent D: AGUA
Method Description: Valoración Flemalis ( Guayacolato de Glicerilo + N-
Acetilcisteina)
Chrom Type: HPLC Channel : 1
Peak Quantitation: AREA
No. Name RT Area

1 N-ACETILCISTEINA 1,79 3241393


2 GUAYACOLATO DE GLICERILO 2,54 20435123

23676516

Peak rejection level: 500000

Page Indicator 13 / 43
D-7000 HSM: MERCK LACHROM Series: 6966 Report: modified System: HPLC

APTITUD DEL SISTEMA

System Suitability Report (Full width)


Processing Method: FLEMALIS BREMYMG
System (acquisition): HPLC
Sample Name: STD FLEMALIS
Injection from this vial: 2 of 3
Sample Description:

RT of Non-Retained Peak: 0,01 min

RT Name k' Asym N Res


(min) (USP) (USP)

1,79 N-ACETILCISTEINA 177,50 1,00 764 ---


2,54 GUAYACOLATO DE GLICERILO 253,33 1,22 1510 2,92

RT Name Alpha S/N Noise


(min) (uV)

1,79 N-ACETILCISTEINA --- --- ---


2,54 GUAYACOLATO DE GLICERILO 1,43 --- ---

Asymmetry warning outside the range of: 0,800 to 2,000


No. of theoretical plates warning at less than: 500
Resolution warning at less than: 0,800
Signal to noise ratio warning at less than: 3

Page Indicator 14 / 43
D-7000 HSM: MERCK LACHROM Series: 6966 Report: modified System: HPLC

Flemalis
Analyzed Date and Time: 29/10/18 04:04 p.m.
Processing Method: FLEMALIS BREMYMG
System(acquisition): HPLC Series:6966
Sample Name: STD FLEMALIS Vial Number: 2
Injection from this vial: 3 of 3 Vial Type: UNK
Sample Description: Volume: 20,0 ul
Chrom Type: HPLC Channel : 1

2000 3261978, N-ACETILCISTEINA

20964532, GUAYACOLATO DE GLICERILO

1500
Intensity (mV)

1000

500

0 1 2 3 4 5 6 7 8 9 10
Retention Time (min)

Acquisition Method: FLEMALIS BREMYMG


Developed by: SAF SAS.
Pump A Type: L-7100
Solvent A: AGUA Solvent B: METANOL
Solvent C: FASE MOVIL Solvent D: AGUA
Method Description: Valoración Flemalis ( Guayacolato de Glicerilo + N-
Acetilcisteina)
Chrom Type: HPLC Channel : 1
Peak Quantitation: AREA
No. Name RT Area

1 N-ACETILCISTEINA 1,80 3261978


2 GUAYACOLATO DE GLICERILO 2,56 20964532

24226510

Peak rejection level: 500000

Page Indicator 15 / 43
D-7000 HSM: MERCK LACHROM Series: 6966 Report: modified System: HPLC

APTITUD DEL SISTEMA

System Suitability Report (Full width)


Processing Method: FLEMALIS BREMYMG
System (acquisition): HPLC
Sample Name: STD FLEMALIS
Injection from this vial: 3 of 3
Sample Description:

RT of Non-Retained Peak: 0,01 min

RT Name k' Asym N Res


(min) (USP) (USP)

1,80 N-ACETILCISTEINA 178,83 0,97 640 ---


2,56 GUAYACOLATO DE GLICERILO 255,33 1,03 --- 1,89

RT Name Alpha S/N Noise


(min) (uV)

1,80 N-ACETILCISTEINA --- --- ---


2,56 GUAYACOLATO DE GLICERILO 1,43 --- ---

Asymmetry warning outside the range of: 0,800 to 2,000


No. of theoretical plates warning at less than: 500
Resolution warning at less than: 0,800
Signal to noise ratio warning at less than: 3

Page Indicator 16 / 43
D-7000 HSM: MERCK LACHROM Series: 6966 Report: modified System: HPLC
Vial Summary for Channel 1
Chrom Type: HPLC Channel : 1
Vial Number: 2
Name Mean Conc 1 1 Conc 1 2 Conc 1 3 Mean
RT(min) CONC1

N-ACETILCISTEINA 1,78 0,000000 0,000000 0,000000 0,000000


GUAYACOLATO DE GLICERILO 2,54 0,000000 0,000000 0,000000 0,000000

Statistics Report for Repetitive Injections (Channel 1)


Vial Number: 2 Injections: 1, 2, 3
Concentration (Conc1)

Name Mean Conc 1 Standard % Standard Variance


Deviation Deviation

N-ACETILCISTEINA 0,000000 0,000E+00 --- 0,000E+00


GUAYACOLATO DE GLICERILO 0,000000 0,000E+00 --- 0,000E+00

Retention Time

Name Mean Standard % Standard Variance


RT(Min) Deviation Deviation

N-ACETILCISTEINA 1,779 2,219E-02 1,25 4,925E-04


GUAYACOLATO DE GLICERILO 2,541 2,428E-02 0,96 5,898E-04

Page Indicator 17 / 43
D-7000 HSM: MERCK LACHROM Series: 6966 Report: modified System: HPLC

Flemalis
Analyzed Date and Time: 29/10/18 04:10 p.m.
Processing Method: FLEMALIS BREMYMG
System(acquisition): HPLC Series:6966
Sample Name: BFL-670817-T12 FLEMALIS Vial Number: 3
Injection from this vial: 1 of 3 Vial Type: UNK
Sample Description: Volume: 20,0 ul
Chrom Type: HPLC Channel : 1

2000

22608523, GUAYACOLATO DE GLICERILO


3409771, N-ACETILCISTEINA

1500
Intensity (mV)

1000

500

0 1 2 3 4 5 6 7 8 9 10
Retention Time (min)

Acquisition Method: FLEMALIS BREMYMG


Developed by: SAF SAS.
Pump A Type: L-7100
Solvent A: AGUA Solvent B: METANOL
Solvent C: FASE MOVIL Solvent D: AGUA
Method Description: Valoración Flemalis ( Guayacolato de Glicerilo + N-
Acetilcisteina)
Chrom Type: HPLC Channel : 1
Peak Quantitation: AREA
No. Name RT Area

1 N-ACETILCISTEINA 1,76 3409771


2 GUAYACOLATO DE GLICERILO 2,52 22608523

26018294

Peak rejection level: 500000

Page Indicator 18 / 43
D-7000 HSM: MERCK LACHROM Series: 6966 Report: modified System: HPLC

APTITUD DEL SISTEMA

System Suitability Report (Full width)


Processing Method: FLEMALIS BREMYMG
System (acquisition): HPLC
Sample Name: BFL-670817-T12 FLEMALIS
Injection from this vial: 1 of 3
Sample Description:

RT of Non-Retained Peak: 0,01 min

RT Name k' Asym N Res


(min) (USP) (USP)

1,76 N-ACETILCISTEINA 175,17 0,99 729 ---


2,52 GUAYACOLATO DE GLICERILO 250,50 1,19 1336 2,81

RT Name Alpha S/N Noise


(min) (uV)

1,76 N-ACETILCISTEINA --- --- ---


2,52 GUAYACOLATO DE GLICERILO 1,43 --- ---

Asymmetry warning outside the range of: 0,800 to 2,000


No. of theoretical plates warning at less than: 500
Resolution warning at less than: 0,800
Signal to noise ratio warning at less than: 3

Page Indicator 19 / 43
D-7000 HSM: MERCK LACHROM Series: 6966 Report: modified System: HPLC

Flemalis
Analyzed Date and Time: 29/10/18 04:16 p.m.
Processing Method: FLEMALIS BREMYMG
System(acquisition): HPLC Series:6966
Sample Name: BFL-670817-T12 FLEMALIS Vial Number: 3
Injection from this vial: 2 of 3 Vial Type: UNK
Sample Description: Volume: 20,0 ul
Chrom Type: HPLC Channel : 1

2000 3499855, N-ACETILCISTEINA

22932913, GUAYACOLATO DE GLICERILO

1500
Intensity (mV)

1000

500

0 1 2 3 4 5 6 7 8 9 10
Retention Time (min)

Acquisition Method: FLEMALIS BREMYMG


Developed by: SAF SAS.
Pump A Type: L-7100
Solvent A: AGUA Solvent B: METANOL
Solvent C: FASE MOVIL Solvent D: AGUA
Method Description: Valoración Flemalis ( Guayacolato de Glicerilo + N-
Acetilcisteina)
Chrom Type: HPLC Channel : 1
Peak Quantitation: AREA
No. Name RT Area

1 N-ACETILCISTEINA 1,77 3499855


2 GUAYACOLATO DE GLICERILO 2,55 22932913

26432768

Peak rejection level: 500000

Page Indicator 20 / 43
D-7000 HSM: MERCK LACHROM Series: 6966 Report: modified System: HPLC

APTITUD DEL SISTEMA

System Suitability Report (Full width)


Processing Method: FLEMALIS BREMYMG
System (acquisition): HPLC
Sample Name: BFL-670817-T12 FLEMALIS
Injection from this vial: 2 of 3
Sample Description:

RT of Non-Retained Peak: 0,01 min

RT Name k' Asym N Res


(min) (USP) (USP)

1,77 N-ACETILCISTEINA 175,83 0,98 628 ---


2,55 GUAYACOLATO DE GLICERILO 253,50 1,09 873 2,48

RT Name Alpha S/N Noise


(min) (uV)

1,77 N-ACETILCISTEINA --- --- ---


2,55 GUAYACOLATO DE GLICERILO 1,44 --- ---

Asymmetry warning outside the range of: 0,800 to 2,000


No. of theoretical plates warning at less than: 500
Resolution warning at less than: 0,800
Signal to noise ratio warning at less than: 3

Page Indicator 21 / 43
D-7000 HSM: MERCK LACHROM Series: 6966 Report: modified System: HPLC

Flemalis
Analyzed Date and Time: 29/10/18 04:22 p.m.
Processing Method: FLEMALIS BREMYMG
System(acquisition): HPLC Series:6966
Sample Name: BFL-670817-T12 FLEMALIS Vial Number: 3
Injection from this vial: 3 of 3 Vial Type: UNK
Sample Description: Volume: 20,0 ul
Chrom Type: HPLC Channel : 1

2000 3419321, N-ACETILCISTEINA

22634665, GUAYACOLATO DE GLICERILO

1500
Intensity (mV)

1000

500

0 1 2 3 4 5 6 7 8 9 10
Retention Time (min)

Acquisition Method: FLEMALIS BREMYMG


Developed by: SAF SAS.
Pump A Type: L-7100
Solvent A: AGUA Solvent B: METANOL
Solvent C: FASE MOVIL Solvent D: AGUA
Method Description: Valoración Flemalis ( Guayacolato de Glicerilo + N-
Acetilcisteina)
Chrom Type: HPLC Channel : 1
Peak Quantitation: AREA
No. Name RT Area

1 N-ACETILCISTEINA 1,77 3419321


2 GUAYACOLATO DE GLICERILO 2,53 22634665

26053986

Peak rejection level: 500000

Page Indicator 22 / 43
D-7000 HSM: MERCK LACHROM Series: 6966 Report: modified System: HPLC

APTITUD DEL SISTEMA

System Suitability Report (Full width)


Processing Method: FLEMALIS BREMYMG
System (acquisition): HPLC
Sample Name: BFL-670817-T12 FLEMALIS
Injection from this vial: 3 of 3
Sample Description:

RT of Non-Retained Peak: 0,01 min

RT Name k' Asym N Res


(min) (USP) (USP)

1,77 N-ACETILCISTEINA 175,50 0,98 636 ---


2,53 GUAYACOLATO DE GLICERILO 251,83 1,09 929 2,50

RT Name Alpha S/N Noise


(min) (uV)

1,77 N-ACETILCISTEINA --- --- ---


2,53 GUAYACOLATO DE GLICERILO 1,43 --- ---

Asymmetry warning outside the range of: 0,800 to 2,000


No. of theoretical plates warning at less than: 500
Resolution warning at less than: 0,800
Signal to noise ratio warning at less than: 3

Page Indicator 23 / 43
D-7000 HSM: MERCK LACHROM Series: 6966 Report: modified System: HPLC
Vial Summary for Channel 1
Chrom Type: HPLC Channel : 1
Vial Number: 3
Name Mean Conc 1 1 Conc 1 2 Conc 1 3 Mean
RT(min) CONC1

N-ACETILCISTEINA 1,77 0,000000 0,000000 0,000000 0,000000


GUAYACOLATO DE GLICERILO 2,53 0,000000 0,000000 0,000000 0,000000

Statistics Report for Repetitive Injections (Channel 1)


Vial Number: 3 Injections: 1, 2, 3
Concentration (Conc1)

Name Mean Conc 1 Standard % Standard Variance


Deviation Deviation

N-ACETILCISTEINA 0,000000 0,000E+00 --- 0,000E+00


GUAYACOLATO DE GLICERILO 0,000000 0,000E+00 --- 0,000E+00

Retention Time

Name Mean Standard % Standard Variance


RT(Min) Deviation Deviation

N-ACETILCISTEINA 1,765 3,333E-03 0,19 1,111E-05


GUAYACOLATO DE GLICERILO 2,529 1,503E-02 0,59 2,259E-04

Page Indicator 24 / 43
D-7000 HSM: MERCK LACHROM Series: 6966 Report: modified System: HPLC

Flemalis
Analyzed Date and Time: 29/10/18 04:28 p.m.
Processing Method: FLEMALIS BREMYMG
System(acquisition): HPLC Series:6966
Sample Name: BFL-670817-T12 FLEMALIS Vial Number: 4
Injection from this vial: 1 of 3 Vial Type: UNK
Sample Description: Volume: 20,0 ul
Chrom Type: HPLC Channel : 1

2000

14944702, GUAYACOLATO DE GLICERILO


2806986, N-ACETILCISTEINA

1500
Intensity (mV)

1000

500

0 1 2 3 4 5 6 7 8 9 10
Retention Time (min)

Acquisition Method: FLEMALIS BREMYMG


Developed by: SAF SAS.
Pump A Type: L-7100
Solvent A: AGUA Solvent B: METANOL
Solvent C: FASE MOVIL Solvent D: AGUA
Method Description: Valoración Flemalis ( Guayacolato de Glicerilo + N-
Acetilcisteina)
Chrom Type: HPLC Channel : 1
Peak Quantitation: AREA
No. Name RT Area

1 N-ACETILCISTEINA 1,74 2806986


2 GUAYACOLATO DE GLICERILO 2,51 14944702

17751688

Peak rejection level: 500000

Page Indicator 25 / 43
D-7000 HSM: MERCK LACHROM Series: 6966 Report: modified System: HPLC

APTITUD DEL SISTEMA

System Suitability Report (Full width)


Processing Method: FLEMALIS BREMYMG
System (acquisition): HPLC
Sample Name: BFL-670817-T12 FLEMALIS
Injection from this vial: 1 of 3
Sample Description:

RT of Non-Retained Peak: 0,01 min

RT Name k' Asym N Res


(min) (USP) (USP)

1,74 N-ACETILCISTEINA 173,33 1,07 600 ---


2,51 GUAYACOLATO DE GLICERILO 249,83 1,12 937 2,50

RT Name Alpha S/N Noise


(min) (uV)

1,74 N-ACETILCISTEINA --- --- ---


2,51 GUAYACOLATO DE GLICERILO 1,44 --- ---

Asymmetry warning outside the range of: 0,800 to 2,000


No. of theoretical plates warning at less than: 500
Resolution warning at less than: 0,800
Signal to noise ratio warning at less than: 3

Page Indicator 26 / 43
D-7000 HSM: MERCK LACHROM Series: 6966 Report: modified System: HPLC

Flemalis
Analyzed Date and Time: 29/10/18 04:34 p.m.
Processing Method: FLEMALIS BREMYMG
System(acquisition): HPLC Series:6966
Sample Name: BFL-670817-T12 FLEMALIS Vial Number: 4
Injection from this vial: 2 of 3 Vial Type: UNK
Sample Description: Volume: 20,0 ul
Chrom Type: HPLC Channel : 1

2000

15015680, GUAYACOLATO DE GLICERILO


2852879, N-ACETILCISTEINA

1500
Intensity (mV)

1000

500

0 1 2 3 4 5 6 7 8 9 10
Retention Time (min)

Acquisition Method: FLEMALIS BREMYMG


Developed by: SAF SAS.
Pump A Type: L-7100
Solvent A: AGUA Solvent B: METANOL
Solvent C: FASE MOVIL Solvent D: AGUA
Method Description: Valoración Flemalis ( Guayacolato de Glicerilo + N-
Acetilcisteina)
Chrom Type: HPLC Channel : 1
Peak Quantitation: AREA
No. Name RT Area

1 N-ACETILCISTEINA 1,75 2852879


2 GUAYACOLATO DE GLICERILO 2,51 15015680

17868559

Peak rejection level: 500000

Page Indicator 27 / 43
D-7000 HSM: MERCK LACHROM Series: 6966 Report: modified System: HPLC

APTITUD DEL SISTEMA

System Suitability Report (Full width)


Processing Method: FLEMALIS BREMYMG
System (acquisition): HPLC
Sample Name: BFL-670817-T12 FLEMALIS
Injection from this vial: 2 of 3
Sample Description:

RT of Non-Retained Peak: 0,01 min

RT Name k' Asym N Res


(min) (USP) (USP)

1,75 N-ACETILCISTEINA 173,83 1,08 598 ---


2,51 GUAYACOLATO DE GLICERILO 250,17 1,13 917 2,47

RT Name Alpha S/N Noise


(min) (uV)

1,75 N-ACETILCISTEINA --- --- ---


2,51 GUAYACOLATO DE GLICERILO 1,44 --- ---

Asymmetry warning outside the range of: 0,800 to 2,000


No. of theoretical plates warning at less than: 500
Resolution warning at less than: 0,800
Signal to noise ratio warning at less than: 3

Page Indicator 28 / 43
D-7000 HSM: MERCK LACHROM Series: 6966 Report: modified System: HPLC

Flemalis
Analyzed Date and Time: 29/10/18 04:40 p.m.
Processing Method: FLEMALIS BREMYMG
System(acquisition): HPLC Series:6966
Sample Name: BFL-670817-T12 FLEMALIS Vial Number: 4
Injection from this vial: 3 of 3 Vial Type: UNK
Sample Description: Volume: 20,0 ul
Chrom Type: HPLC Channel : 1

2000

14975305, GUAYACOLATO DE GLICERILO


2842271, N-ACETILCISTEINA

1500
Intensity (mV)

1000

500

0 1 2 3 4 5 6 7 8 9 10
Retention Time (min)

Acquisition Method: FLEMALIS BREMYMG


Developed by: SAF SAS.
Pump A Type: L-7100
Solvent A: AGUA Solvent B: METANOL
Solvent C: FASE MOVIL Solvent D: AGUA
Method Description: Valoración Flemalis ( Guayacolato de Glicerilo + N-
Acetilcisteina)
Chrom Type: HPLC Channel : 1
Peak Quantitation: AREA
No. Name RT Area

1 N-ACETILCISTEINA 1,75 2842271


2 GUAYACOLATO DE GLICERILO 2,51 14975305

17817576

Peak rejection level: 500000

Page Indicator 29 / 43
D-7000 HSM: MERCK LACHROM Series: 6966 Report: modified System: HPLC

APTITUD DEL SISTEMA

System Suitability Report (Full width)


Processing Method: FLEMALIS BREMYMG
System (acquisition): HPLC
Sample Name: BFL-670817-T12 FLEMALIS
Injection from this vial: 3 of 3
Sample Description:

RT of Non-Retained Peak: 0,01 min

RT Name k' Asym N Res


(min) (USP) (USP)

1,75 N-ACETILCISTEINA 174,17 1,08 607 ---


2,51 GUAYACOLATO DE GLICERILO 250,33 1,14 943 2,49

RT Name Alpha S/N Noise


(min) (uV)

1,75 N-ACETILCISTEINA --- --- ---


2,51 GUAYACOLATO DE GLICERILO 1,44 --- ---

Asymmetry warning outside the range of: 0,800 to 2,000


No. of theoretical plates warning at less than: 500
Resolution warning at less than: 0,800
Signal to noise ratio warning at less than: 3

Page Indicator 30 / 43
D-7000 HSM: MERCK LACHROM Series: 6966 Report: modified System: HPLC
Vial Summary for Channel 1
Chrom Type: HPLC Channel : 1
Vial Number: 4
Name Mean Conc 1 1 Conc 1 2 Conc 1 3 Mean
RT(min) CONC1

N-ACETILCISTEINA 1,75 0,000000 0,000000 0,000000 0,000000


GUAYACOLATO DE GLICERILO 2,51 0,000000 0,000000 0,000000 0,000000

Statistics Report for Repetitive Injections (Channel 1)


Vial Number: 4 Injections: 1, 2, 3
Concentration (Conc1)

Name Mean Conc 1 Standard % Standard Variance


Deviation Deviation

N-ACETILCISTEINA 0,000000 0,000E+00 --- 0,000E+00


GUAYACOLATO DE GLICERILO 0,000000 0,000E+00 --- 0,000E+00

Retention Time

Name Mean Standard % Standard Variance


RT(Min) Deviation Deviation

N-ACETILCISTEINA 1,748 4,194E-03 0,24 1,759E-05


GUAYACOLATO DE GLICERILO 2,511 2,545E-03 0,10 6,481E-06

Page Indicator 31 / 43
D-7000 HSM: MERCK LACHROM Series: 6966 Report: modified System: HPLC

Flemalis
Analyzed Date and Time: 29/10/18 04:46 p.m.
Processing Method: FLEMALIS BREMYMG
System(acquisition): HPLC Series:6966
Sample Name: BFL-670817-T12 FLEMALIS Vial Number: 5
Injection from this vial: 1 of 3 Vial Type: UNK
Sample Description: Volume: 20,0 ul
Chrom Type: HPLC Channel : 1

2000

15462838, GUAYACOLATO DE GLICERILO


3065012, N-ACETILCISTEINA

1500
Intensity (mV)

1000

500

0 1 2 3 4 5 6 7 8 9 10
Retention Time (min)

Acquisition Method: FLEMALIS BREMYMG


Developed by: SAF SAS.
Pump A Type: L-7100
Solvent A: AGUA Solvent B: METANOL
Solvent C: FASE MOVIL Solvent D: AGUA
Method Description: Valoración Flemalis ( Guayacolato de Glicerilo + N-
Acetilcisteina)
Chrom Type: HPLC Channel : 1
Peak Quantitation: AREA
No. Name RT Area

1 N-ACETILCISTEINA 1,74 3065012


2 GUAYACOLATO DE GLICERILO 2,49 15462838

18527850

Peak rejection level: 500000

Page Indicator 32 / 43
D-7000 HSM: MERCK LACHROM Series: 6966 Report: modified System: HPLC

APTITUD DEL SISTEMA

System Suitability Report (Full width)


Processing Method: FLEMALIS BREMYMG
System (acquisition): HPLC
Sample Name: BFL-670817-T12 FLEMALIS
Injection from this vial: 1 of 3
Sample Description:

RT of Non-Retained Peak: 0,01 min

RT Name k' Asym N Res


(min) (USP) (USP)

1,74 N-ACETILCISTEINA 173,17 1,08 601 ---


2,49 GUAYACOLATO DE GLICERILO 248,00 1,11 1009 2,50

RT Name Alpha S/N Noise


(min) (uV)

1,74 N-ACETILCISTEINA --- --- ---


2,49 GUAYACOLATO DE GLICERILO 1,43 --- ---

Asymmetry warning outside the range of: 0,800 to 2,000


No. of theoretical plates warning at less than: 500
Resolution warning at less than: 0,800
Signal to noise ratio warning at less than: 3

Page Indicator 33 / 43
D-7000 HSM: MERCK LACHROM Series: 6966 Report: modified System: HPLC

Flemalis
Analyzed Date and Time: 29/10/18 04:52 p.m.
Processing Method: FLEMALIS BREMYMG
System(acquisition): HPLC Series:6966
Sample Name: BFL-670817-T12 FLEMALIS Vial Number: 5
Injection from this vial: 2 of 3 Vial Type: UNK
Sample Description: Volume: 20,0 ul
Chrom Type: HPLC Channel : 1

2000

15840256, GUAYACOLATO DE GLICERILO


2905082, N-ACETILCISTEINA

1500
Intensity (mV)

1000

500

0 1 2 3 4 5 6 7 8 9 10
Retention Time (min)

Acquisition Method: FLEMALIS BREMYMG


Developed by: SAF SAS.
Pump A Type: L-7100
Solvent A: AGUA Solvent B: METANOL
Solvent C: FASE MOVIL Solvent D: AGUA
Method Description: Valoración Flemalis ( Guayacolato de Glicerilo + N-
Acetilcisteina)
Chrom Type: HPLC Channel : 1
Peak Quantitation: AREA
No. Name RT Area

1 N-ACETILCISTEINA 1,75 2905082


2 GUAYACOLATO DE GLICERILO 2,52 15840256

18745338

Peak rejection level: 500000

Page Indicator 34 / 43
D-7000 HSM: MERCK LACHROM Series: 6966 Report: modified System: HPLC

APTITUD DEL SISTEMA

System Suitability Report (Full width)


Processing Method: FLEMALIS BREMYMG
System (acquisition): HPLC
Sample Name: BFL-670817-T12 FLEMALIS
Injection from this vial: 2 of 3
Sample Description:

RT of Non-Retained Peak: 0,01 min

RT Name k' Asym N Res


(min) (USP) (USP)

1,75 N-ACETILCISTEINA 174,00 1,05 610 ---


2,52 GUAYACOLATO DE GLICERILO 251,33 1,13 972 2,55

RT Name Alpha S/N Noise


(min) (uV)

1,75 N-ACETILCISTEINA --- --- ---


2,52 GUAYACOLATO DE GLICERILO 1,44 --- ---

Asymmetry warning outside the range of: 0,800 to 2,000


No. of theoretical plates warning at less than: 500
Resolution warning at less than: 0,800
Signal to noise ratio warning at less than: 3

Page Indicator 35 / 43
D-7000 HSM: MERCK LACHROM Series: 6966 Report: modified System: HPLC

Flemalis
Analyzed Date and Time: 29/10/18 04:58 p.m.
Processing Method: FLEMALIS BREMYMG
System(acquisition): HPLC Series:6966
Sample Name: BFL-670817-T12 FLEMALIS Vial Number: 5
Injection from this vial: 3 of 3 Vial Type: UNK
Sample Description: Volume: 20,0 ul
Chrom Type: HPLC Channel : 1

2000

15680865, GUAYACOLATO DE GLICERILO


3070558, N-ACETILCISTEINA

1500
Intensity (mV)

1000

500

0 1 2 3 4 5 6 7 8 9 10
Retention Time (min)

Acquisition Method: FLEMALIS BREMYMG


Developed by: SAF SAS.
Pump A Type: L-7100
Solvent A: AGUA Solvent B: METANOL
Solvent C: FASE MOVIL Solvent D: AGUA
Method Description: Valoración Flemalis ( Guayacolato de Glicerilo + N-
Acetilcisteina)
Chrom Type: HPLC Channel : 1
Peak Quantitation: AREA
No. Name RT Area

1 N-ACETILCISTEINA 1,75 3070558


2 GUAYACOLATO DE GLICERILO 2,51 15680865

18751423

Peak rejection level: 500000

Page Indicator 36 / 43
D-7000 HSM: MERCK LACHROM Series: 6966 Report: modified System: HPLC

APTITUD DEL SISTEMA

System Suitability Report (Full width)


Processing Method: FLEMALIS BREMYMG
System (acquisition): HPLC
Sample Name: BFL-670817-T12 FLEMALIS
Injection from this vial: 3 of 3
Sample Description:

RT of Non-Retained Peak: 0,01 min

RT Name k' Asym N Res


(min) (USP) (USP)

1,75 N-ACETILCISTEINA 174,00 1,08 603 ---


2,51 GUAYACOLATO DE GLICERILO 250,00 1,13 1013 2,53

RT Name Alpha S/N Noise


(min) (uV)

1,75 N-ACETILCISTEINA --- --- ---


2,51 GUAYACOLATO DE GLICERILO 1,44 --- ---

Asymmetry warning outside the range of: 0,800 to 2,000


No. of theoretical plates warning at less than: 500
Resolution warning at less than: 0,800
Signal to noise ratio warning at less than: 3

Page Indicator 37 / 43

You might also like